The document discusses the adoption of electronic batch manufacturing records (eBMR) and manufacturing execution systems (MES) in the pharmaceutical industry. It notes that pharmaceutical companies are under pressure to minimize human errors and ensure regulatory compliance, driving adoption of technology solutions. While ERP systems tracked workflows and materials, they lacked control over manufacturing processes. eBMR and MES help address this by enabling equipment to communicate process parameters and measurements digitally in real-time rather than relying on manual recording. This increases accuracy, productivity and ensures compliance. The document provides an overview of Base E12 MES and eBMR software.